Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 4, 1998, Pages 436-443

  Lopez Velez, Rogelio ^a   Perez Molina, Jose A ^a   Guerrero, Antonio ^a   Baquero, Fernando ^a   Villarrubia, Jesus ^a   Escribano, Luis ^a   Bellas, Carmen ^a   Perez Corral, Francisco ^a   Alvar, Jorge ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; MEGLUMINE ANTIMONATE; RECOMBINANT GAMMA INTERFERON;

ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERAMYLASEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIASIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PROGNOSIS; SPAIN; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 0031921067     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.436     Document Type: Article

References (44)

1. Fernandez-Guerrero ML, Aguado JM, Buzin L, Barros C, Montalban C, Martin T, Bouza E, 1987. Visceral leishmaniasis in immunocompromised hosts. Am J Med 83: 1098-1102.
2. Montalban C, Martinez-Fernandez R, Calleja JL, Garcia-Diaz JD, Rubio R, Dronda F, Moreno S, Yebra M, Barros C, Cobo J, Martinez MC, Ruiz F Costa, J, 1989. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 11: 655-660.
3. Berenguer J, Moreno S, Cercenado E, Bernaldo de Quiros JCL, Garcia de la Fuente A, Bouza E, I989. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 111: 129-132.
4. WHO, 1994. Acquired immunodeficiency syndrome (AIDS) - Data as of December 1994. Wkly Epidemiol Rec 70: 5-8.
5. WHO, 1995. Report on the Consultative Meeting on Leishtnania/HlV Co-Infection 1995. Geneva: World Health Organization, WHO/LEISH/95.35.
6. Desjeux P, 1992. Human leishmaniases: epidemiology and public health aspects. World Health Star Q 45: 267-275.
7. Rosenthal E, Marty P, Poizot-Martin Y, Rcynes J, Pratlong F, Lafeuillade A, Jaubert D, Boulat O, Dereure J, Gambarelli F, Gastaut JA, Dujardin P, Dellamonica P, Cassuto JP, 1995. Visceral leishmaniasis and HIV co-infection in southern France. Trans R Soc Trop Med Hyg 89: 159-162.
8. Medrano FJ, Hernandez-Quero J, Jimenez E, Pineda J, Rivero A, Sanchez-Quijano A, Velez Y, Viciana P, Castillo R, Reyes M, Carvajal F, Leal M, Lissen E, 1992. Visceral leishmaniasis in HIV - l -infected individuals: a common opportunistic infection in Spain? AIDS 6: 1499-1503.
9. CDC, 1993. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly rep 41 (PR-17): 1-19.
10. Park RAA, 1992. European AIDS definition. Lancet 339: 671.
11. Maazoun R, Lanotte G, Pasteur N, Rioux JA, Kennon MF, Pratlong F, 1981. Ecologie des leishmanioses dans le Sud de la France. Contribution a l'analyse chimiotaxonomique des parasites de la leishmaniose viscerale mediterraneenne. A propos de 55 souches isolees en Cevennes, Cote d'Azur, Corse et Tunisie. Ann Parasitol Hum Comp 56: 131-146.
12. Rioux JA, Lanotte G Serres E, Pratlong F, Bastien P, Perieres J, 1990. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp 65: 111-125.
13. Abraira V, Zaplana J, 1984. PRESTA: Un Paquete de Procesamientos Estadisticos. Gijon, Spain: Proceedings de la Conferencia Iberoamericana de Bioingenieria, 101.
14. Botet J, Portus M, 1993. La Leishmaniosis en la España peninsular. Revision historico-bibliografica (1912-1985). Rev San Hig Pub 67: 255-266.
15. Alvar J, 1994. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol Today 10: 160-163.
16. Marty P, Lelievre A, Quaranta JF, Rahal A, Gari-Toussaint M, La Fichoux Y, 1994. Use of the leishmanin skin test and Western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg 88: 658-659.
17. Martinez P, De la Vega E, Laguna F, Soriano V, Puente S, Moreno V, Sentchordi MJ, Garcia-Auado C, Gonzalez la Hoz J, 1993. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 7: 227-230.
18. Lopez-Velez R, Laguna F, Alvar J, Perez-Molina JA, Molina R, Martinez P, Villarrubia J, 1995. Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol 33: 937-939.
19. Molina R, Canavate C, Cercenado E, Laguna F, Lopez-Velez R, Alvar J, 1994. Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. AIDS 8: 277-279.
20. Vigilancia Epidemiologica del SIDA/VIH, 1994. Informe no. 14. Madrid: Comunidad de Madrid. Consejeria de Salud. Direccion General de Prevencion y Promocion de la Salud.
21. Alvar J, Jimenez M, 1994. Could infected drug-users be potential Leishmania infantum reservoirs? AIDS 8: 854.
22. Jimenez MI, Ferer-Dufol M, Canavate C, Gutierrez-Solar B, Molina R, Laguna F, Lopez-Velez R, Cercenado E, Dauden E, Blazquez J, Ladron de Guevara C, Gomez J, de la Torre J, Barros C, Altes J, Serra T, Alvar J, 1995. Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiol Lett 131: 197-204.
23. Pratlong JP, Dedet JP, Marty P, Portus M, Deniau M, Dedeure J, Abranches P, Reynes J, Martini A, Lefebvre M, Rioux JA, 1995. Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis 172: 323-326.
24. Russell DGV, Xu S, Chakraborty P, 1992. Intracellular trafficking and the parasitophorus vacuole of Leishmania mexicana-infected macrophages. J Cell Sci 103: 1193-1210.
25. Matheron S, Cabie A, Parquin F, Mayaud C, Roux P, Antoine M, Chougnet C, Coulaud JP, 1992. Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS 6: 238-239.
26. Laguna F, Garcia-Samaniego J, Soriano V Valencia E, Redondo C Alonso MJ, Gonzalez la Hoz JM, 1994. Gastro-intestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis 19: 48-53.
27. Ho JL, Badaro R, Schwartz A, Dinarello CA, Gelfand JA, Sobel J, Barral A, Barral Netto M, Carvalho EM, Reed SG, Johnson WD Jr, 1992. Diminished in vitro production of interleukin-1 and tumor necrosis factor during acute visceral leishmaniasis and recovery after therapy. J Infect Dis 165: 1094-1102.
28. Montalban C, Calleja JL, Erice A, Laguna F, Clotett B, Podzamczer D, Cobo J, Mallolas J, Yebra M, Gallego A, 1990. Visceral leishmaniasis in patients infected with human immunodeficiency virus. J Infect 21: 261-270.
29. Duxburry ER, Sadun HE, 1964. Fluorescent antibody test for the serodiagnosis of visceral leishmaniasis. Am J Trop Med Hyg 13: 525-529.
30. Shaw JJ, Voller A, 1964. The detection of circulating antibody to kala-azar by means of immunofluorescence techniques. Trans R Soc Trop Med Hyg 58: 349-352.
31. Gari-Toussaint M, Lelievre A, Marty P, Le Fichoux Y, 1994. Contribution of serological test to the diagnosis of visceral leishmaniasis in patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg 88: 301-302.
32. Miralles P, Moreno S, Perez-Tascon M, Cosin J, Diaz MD, Bouza E, 1995. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 20: 872-875.
33. Mishra M, Biswas UK, Jha DM, Khan AB, 1992. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet 340: 1256-1257.
34. Mishra M, Biswas UK, Khan AB, 1994. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet 344: 1599-1600.
35. Badaro R, Falcoff E, Badaro FS, Carvalho EM, Pedral-Sampaio D, Barral A, Carvalho JS, Barral-Netto M, Brandely M, Silcva L, Bina JC, Teixeira R, Falcoff R, Rocha H, Ho JL, Johnson WD Jr, 1990. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New Engl J Med 322: 16-21.
36. De Gorgolas M, Castrillo JM, Fernandez Guerrero ML, 1993. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma. Clin Infect Dis 17: 56-58.
37. Davidson RN, Russo R, 1994. Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin Infect Dis 19: 560.
38. Gasser RA, Magill AJ Jr, Oster N, Franke DE, Grogl M, Berman JD, 1994. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 18: 83-90.
39. Halim MA, Alfurayh O, Kalim ME, Dammas S, Al-Eisa A. Damanhouri G, 1993. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin Infect Dis 16: 397-399.
40. Ribera E, Ocana I, Otero J, Cortes E, Gasser I, Pahissa A, 1996. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med 100: 496-501.
41. Ena J, Amador C, Pasquau F, Carbonell C, Benito C, Gutierrez F, Vilar A, 1994. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. Clin Infect Dis 18: 901-904.
42. Najean Y, Rain JD, 1994. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med 123: 415-420.
43. Graham NM, Piantadosi S, Park LP, Phair JP, Rinaldo CR, Fahey JL, 1993. CD4+ lymphocyte response to zidovudine as predictor of AIDS-free time and survival. J Acquir Immune Defic Syndr 6: 1258-1266.
44. Gradoni L, Scalone A, Gramiccia M, Troiani M, 1996. Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS 10: 785-791.